Posted on 05/29/2020 6:23:32 AM PDT by Jayster
'These medications need to be widely available and promoted immediately for physicians to prescribe,' the American Journal of Epidemiology says.
prestigious medical journal is criticizing news media coverage of hydroxychlorioquine in the battle against coronavirus, saying there is evidence the anti-malarial drug combined with the antibiotic azithromycin helps in the early stages of outpatient treatment.
"These medications need to be widely available and promoted immediately for physicians to prescribe," the American Journal of Epidemiology reported in an article published this week that pushed back against claims the regimen has been dangerous or ineffective in all cases.
"Hydroxychloroquine plus azithromycin has been widely misrepresented in both clinical reports and public media, and outpatient trials results are not expected until September," the journal noted, urging medical professionals and the public to recognize there are different stages of the disease that may require different treatments.
The article said the two candidate medications which have been widely reported - remdesivir and hydroxychloroquine plus azithromycin -- need to be looked at differently.
(Excerpt) Read more at justthenews.com ...
This ought to change some minds in the deep state media.
/s
I wonder how much our domestic enemies have spent on the anti-HQ campaign... perhaps more than they would have spent on a pro-HQ campaign if Trump had said he was against it?
Zinc, zinc, zinc?
The media will say its ‘anecdotal’.
Re: The media will say its ‘anecdotal’.
***
So will the illustrious epidemiologist Fauxci.
And I’ll bet you a dozen masks that Tony Fauci has the five most current issues of The American Journal of Epidemiology on his coffee table.
BTTT
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.